University of Oxford Department of Oncology
banner
oncology.ox.ac.uk
University of Oxford Department of Oncology
@oncology.ox.ac.uk
Reposted by University of Oxford Department of Oncology
In case you missed it!

Sarah Blagden @oncology.ox.ac.uk featured in Channel 4’s Cancer Detectives: Finding the Cures last week, sharing ground-breaking precision-prevention research at Oxford!

Read more ⬇️

@sarahblagden.bsky.social @medsci.ox.ac.uk

www.cancer.ox.ac.uk/news/profess...
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of...
www.cancer.ox.ac.uk
November 25, 2025 at 10:39 AM
Reposted by University of Oxford Department of Oncology
Oxford Professor Sarah Blagden, @oncology.ox.ac.uk appears in the first episode of Cancer Detectives: Finding the Cures on @Channel4 tonight!

📺 Watch at 9pm, Thurs 20 Nov, or stream on Channel 4.

Brought to you by @CR_UK.

#CancerDetectives #CancerPrevention

www.channel4.com/programmes/c...
Cancer Detectives: Finding the Cures
Three trailblazing scientists take on cancer, changing peoples’ lives, right now
www.channel4.com
November 20, 2025 at 11:47 AM
Reposted by University of Oxford Department of Oncology
We’re thrilled to partner with Channel 4 on ‘Cancer Detectives: Finding the Cures’ - a new series which is shining a light on three trailblazing scientists taking on cancer, and explores how their work is changing patients’ lives right now. 👇 1/2
November 20, 2025 at 9:37 AM
World’s first lung cancer prevention vaccine gets £2 million for clinical trial

People at high risk of lung cancer will soon be able to receive the experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial.

@medsci.ox.ac.uk @oxfordcancer.bsky.social
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine ca...
www.oncology.ox.ac.uk
November 17, 2025 at 2:58 PM
Reposted by University of Oxford Department of Oncology
Next up in the Meet The MILI Team series, is Dr Schaida Schirwani.

Dr Schirwani is a genetics consultant and is part of the MILI team at University Hospital Southampton.

#LFS #LiFraumeni @uhsft.bsky.social @oncology.ox.ac.uk
@oxfordcancer.bsky.social

tp53.co.uk/lfs-tp53/
November 13, 2025 at 1:23 PM
Reposted by University of Oxford Department of Oncology
What if we could stop #Cancer before it even starts?

Prof. Sarah Blagden @oncology.ox.ac.uk & PPI contributor Anna Fry discuss novel cancer prevention research on the @oxfordsparks.bsky.social podcast.

🎧 www.oxfordsparks.ox.ac.uk/podcasts/cou...

@sarahblagden.bsky.social @medsci.ox.ac.uk
November 12, 2025 at 1:02 PM
INTREPID is one of five interdisciplinary teams launched
as part of a new UK initiative to transform disease research through the development of advanced human tissue models.

The team will evaluate & optimise the use of patient-derived explants as tumour models.

Learn more:
Oxford joins £15.9m national initiative to transform cancer research
Oxford scientists are part of a new £15.9 million UK initiative to transform disease research through the development of advanced human tissue models. The INTREPID project will evaluate and optimise
www.ox.ac.uk
November 12, 2025 at 10:00 AM
Reposted by University of Oxford Department of Oncology
Funded PhD available working with us on tumour hypoxia and radiosensitivity at @oncology.ox.ac.uk @ox.ac.uk Closing date 2nd Dec www.oncology.ox.ac.uk/study-with-u...
Oxford Wolfson Marriott Graduate Scholarship: Investigating changes in RNA-binding proteins in hypoxia as a means of increasing radiosensitivity
www.oncology.ox.ac.uk
November 5, 2025 at 4:19 PM
Sruthi Shakthivel is a technician in the Translational Support Unit (TSU), a dedicated unit within @octooxford.bsky.social that focuses on the operational & scientific side of biological sample management in clinical trials.

Sruthi shares insights on the mission of the TSU & what her role involves:
Staff Spotlight: Working as a Technician in the Translational Support Unit
Sruthi Shakthivel works as a technician in the Translational Support Unit (TSU), a dedicated unit within the Oncology Clinical Trials Office (OCTO) that focuses on the operational and scientific side…
buff.ly
November 3, 2025 at 4:34 PM
Reposted by University of Oxford Department of Oncology
Members of the Department of Oncology were at ESMO 2025 in Berlin last week to present their research, chair sessions, and network with collaborators.

Read about some of the highlights from our department’s contributions to the congress:

www.oncology.ox.ac.uk/news/esmo-2025
Oxford Oncology at ESMO 2025
Members of the Department of Oncology attended ESMO earlier this month to present their research, chair sessions, and network with collaborators from across Europe and beyond. Read the highlights from...
www.oncology.ox.ac.uk
October 29, 2025 at 12:52 PM
Reposted by University of Oxford Department of Oncology
Explore internships and graduate roles with organisations from a variety of technical area the Science, Engineering & Technology Fair @ox.ac.uk

📅 Saturday 25 October 2025
⌚ Exhibitors from 10:30-13:30; Pre-fair talks from 09:45
📍 Examination Schools, OX1 4BG

👉 www.careers.ox.ac.uk/set
October 22, 2025 at 8:11 AM
We would like to congratulate our MSc course prize winners, who each achieved the highest mark in their cohort for 2024-25.

Many congratulations to Maria, Jack, Carla & Yael on this outstanding achievement. We are confident they have impressive futures ahead as leaders in the field of oncology.
Celebrating Excellence: MSc Prize Winners 2024–25
The 2024-25 academic year has drawn to a close and we are saying goodbye to an exceptional cohort of students across our MSc programmes. In particular, we would like to congratulate our course prize w...
www.oncology.ox.ac.uk
October 20, 2025 at 3:01 PM
For Senior Research Technician Erin Jarvis, the flexibility of the MSc in Precision Cancer Medicine offered the perfect opportunity to enhance her knowledge and skills, while continuing her work in the lab.

Erin shares her experience of the course & how it helped her prepare to pursue a PhD 👇
From MSc to PhD: Erin’s Journey in Precision Cancer Medicine
For Senior Research Technician Erin Jarvis, the flexibility of the MSc in Precision Cancer Medicine course offered the perfect opportunity to enhance her knowledge and skills, while continuing her wor...
www.oncology.ox.ac.uk
October 13, 2025 at 4:39 PM
Reposted by University of Oxford Department of Oncology
Excited to share I’ve recently started as a group leader at the University of Oxford @oncology.ox.ac.uk, @ox.ac.uk

Feeling grateful for the people who’ve helped me get here, and looking forward to growing a lab that asks important questions (and hopefully finds some answers).
#NewPI #CancerResearch
October 12, 2025 at 7:21 PM
Reposted by University of Oxford Department of Oncology
💚 Mental health matters every day. Whether you’re thriving or finding things tough, we have resources available to support you. From Spectrum.Life’s 24/7 free and confidential service, to Thriving at Oxford, and peer support.

Find what helps you: www.medsci.ox.ac.uk/...
October 10, 2025 at 8:00 AM
Fantastic news from Dr Peter Kok-Ting Wan, who has been awarded a fellowship from @pancreaticcanuk.bsky.social

Dr Wan’s fellowship will focus on developing a novel antibody-based immunotherapy designed to overcome fibroblast-mediated shielding & restore immune activity within pancreatic tumours ⬇️
Dr Peter Wan Awarded Pancreatic Cancer UK Fellowship to Develop New Immunotherapy for Pancreatic Cancer
Dr Peter Kok-Ting Wan, PhD, postdoctoral researcher at the Department of Oncology, has been awarded a prestigious fellowship from Pancreatic Cancer UK to develop a new immunotherapy for pancreatic can...
www.oncology.ox.ac.uk
October 9, 2025 at 10:23 AM
Grace Frost studied MSc Medical Physics with Radiobiology to kickstart her career in space research

She is now working as a bioinformatician at the Oxford Space Innovation lab, the first to send human tissue samples to the ISS, looking at the impact of microgravity & cosmic radiation on ageing.
Alumni Diaries: Launching a Career in Space Research
Grace Frost completed her master's in Medical Physics and Radiobiology at the Department of Oncology in 2024. Since graduating, Grace has joined the Oxford Space Innovation Lab at the University of…
buff.ly
October 7, 2025 at 11:42 AM
Reposted by University of Oxford Department of Oncology
The Knowledge Centre Library (in the Old Road Campus Research Building) is holding a Welcome Event for new and existing University members, from the 6 - 10 October 2025, 12 - 1pm. Free tea, coffee and biscuits will be available.
@oxpop.bsky.social
@ndm.ox.ac.uk
@medsci.ox.ac.uk
@oncology.ox.ac.uk
October 6, 2025 at 10:01 AM
New findings in @natcomms.nature.com demonstrate the impact of allelic variation on monocyte context-specific splicing.

@bpfairfax.bsky.social & colleagues show that many risk polymorphisms lead to differential gene splicing.

➡️Reveals putative mechanisms of diverse disease risk alleles inc. cancer
Genetic determinants of monocyte splicing are enriched for disease susceptibility loci - Nature Communications
Our understanding of variation in monocyte context-specific splicing and transcript usage is limited. Here, the authors find genetic variants that affect gene splicing in monocytes in specific contexts, including several diseases, and in response to stimulants.
www.nature.com
October 3, 2025 at 11:01 AM
Reposted by University of Oxford Department of Oncology
Our Peer Mentoring Scheme, supported by the UK Civil Service Policy Profession is open for applications!

Since 2021, it has brought together nearly 200 @ox.ac.uk researchers and policy professionals from across UK give and local authorities. Apply and share!

1/5

www.ox.ac.uk/research/usi...
September 30, 2025 at 10:31 AM
📝The MSc in Radiobiology course is now accepting applications for 2026/27.

The course looks in depth at principles of radiobiology & their clinical applications, for those interested in careers in academic research, clinical practice or industry.

📍See oncology.ox.ac.uk/study-with-us for details
September 29, 2025 at 3:28 PM
Reposted by University of Oxford Department of Oncology
Lots of congratulations to Tianming Zhao @oncology.ox.ac.uk who defended his MRes fantastically yesterday! This is a great story led by @mtjackson101.bsky.social (who defended his DPhil in Jan) that we hope to share soon - congratulations Tianming!
September 20, 2025 at 8:47 AM
What an achievement! Delighted to have Dr Orlando join our team 👩‍🔬🧪

@oxfordcancer.bsky.social @medsci.ox.ac.uk
Excited to announce that this week I have officially started my lab at @oncology.ox.ac.uk. Grateful for all the support I received by colleagues and mentors Adam Mead, Irene Roberts, @bethpsaila.bsky.social, @houlstonlab-icr.bsky.social and many others without whom this would have not been possible.
September 19, 2025 at 9:57 AM
💡New insights into how FLASH RT kills cancer cells while minimising damage to healthy tissues.

New data from @moonejung.bsky.social's lab has demonstrated that FLASH RT induces iron-dependent cell death in tumour cells but not in healthy cells, which may contribute to its tissue sparing effect⬇️
Iron Levels Found to Play a Key Role in FLASH Radiotherapy’s Tissue-Sparing Effect
Researchers in the Department of Oncology have uncovered new insights into how FLASH radiation therapy kills cancer cells while minimising damage to healthy tissues. Published in Cell Death & Disease,...
www.oncology.ox.ac.uk
September 16, 2025 at 11:05 AM